Re-runs extraction for each period with period-end year from max(2023, current year − 2) through the current year, oldest first (up to three reporting years). This can take a long time.
Global pharma—oncology, vaccines, hospital acute care, and animal health.
Sector: Health care
US_MRK
No intraday sparkline from the default exchange feed; Yahoo or day change may still appear below when available.
No price chart.
Net debt (table and EV/EBITDA): |short-term borrowings| + |long-term borrowings| + |other financial liabilities| when extracted + |non-controlling interest| when extracted − |cash and equivalents|; amounts in millions of the reporting currency.
Shares: sec_companyfacts/310158
| Period | Issues |
|---|---|
| 2023-03-31 Q1 | ⚠Warn 1 |
| 2023-06-30 Q2 | ✗Errors 1Warn 1 |
| 2023-09-30 Q3 | ⚠Warn 1 |
| 2023-12-31 FY | ⚠Warn 2 |
| 2024-03-31 Q1 | ⚠Warn 1 |
| 2024-06-30 Q2 | ⚠Warn 1 |
| 2024-09-30 Q3 | ⚠Warn 1 |
| 2024-12-31 FY | ⚠Warn 1 |
| 2025-03-31 Q1 | ⚠Warn 1 |
| 2025-06-30 Q2 | ⚠Warn 1 |
| 2025-09-30 Q3 | ⚠Warn 1 |
| 2025-12-31 FY | ⚠Warn 3 |
| 2026-03-31 Q1 | ✗Errors 2Warn 2 |
Monetary columns are in B USD, one decimal; scale (K/M/B/T) keeps values readable. For the period (default) shows P&L and cash flow for that row’s reporting window: quarterly amounts when the feed uses quarter-duration facts (typical US 10-Q revenue and income), quarterly cash flows after stripping YTD where only cumulative tags exist, and an implied Q4 on 31 Dec FY rows (P&L: FY minus Q1–Q3; operating / investing cash flow: FY 12m minus 9M YTD to 30 Sep when sourced from SEC builder evidence) so they match 10-Q scale. Some issuers still use cumulative YTD minus the prior row in the same calendar year. As reported shows values stored on each row (e.g. full-year on FY). Balance sheet is always as reported. Source JSON may use millions etc.; conversion uses amounts_unit per row.
| Date | Period | Status | RevenueB USD | Operating profitB USD | D&AB USD | EBITDAB USD | Net profitB USD | Operating CFB USD | Capex + M&AB USD | AssetsB USD | EquityB USD | ROE (annualized) | Net debtB USD | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | Q1 2026 (3M) | OK | 16.3 y/y 4.9% | — y/y — | 0.6 y/y 15.7% | — y/y — | -4.2 y/y -183.5% | 3.9 | -9.8 | 128.7 y/y 11.8% | 45.9 y/y -5.1% | -34.4% | 43.8 | Link |
| 2025-12-31 | FY 2025 (12M) | OK | 16.4 y/y 5.0% | 3.4 y/y -18.0% | 4.3 y/y 46.9% | 7.7 y/y 8.8% | 3.0 y/y -20.8% | 2.9 | -11.1 | 136.9 y/y 16.9% | 52.6 y/y 13.6% | 35.0% | 35.1 | Link |
| 2025-09-30 | Q3 2025 (3M) | OK | 17.3 y/y 3.7% | 6.7 y/y 64.9% | 0.5 y/y -3.8% | 7.3 y/y 56.7% | 5.8 y/y 83.2% | 7.8 | -1.0 | 129.5 y/y 10.2% | 51.9 y/y 16.5% | 15.3% | 23.2 | Link |
| 2025-06-30 | Q2 2025 (3M) | OK | 15.8 y/y -1.9% | 5.0 y/y -16.8% | 0.5 y/y 0.0% | 5.5 y/y -15.4% | 4.4 y/y -18.8% | 3.3 | -0.8 | 117.5 y/y 4.3% | 49.0 y/y 12.4% | 36.4% | 27.4 | Link |
| 2025-03-31 | Q1 2025 (3M) | OK | 15.5 y/y -1.6% | 5.9 y/y 4.1% | 0.5 y/y -1.8% | 6.4 y/y 3.6% | 5.1 y/y 6.7% | 2.5 | -1.3 | 115.1 y/y 8.8% | 48.3 y/y 19.7% | 42.9% | 26.2 | Link |
| 2024-12-31 | FY 2024 (12M) | OK | 15.6 y/y 6.8% | 4.2 y/y — | 2.9 y/y 16.8% | 7.1 y/y — | 3.7 y/y 405.3% | 3.5 | -0.9 | 117.1 y/y 9.8% | 46.3 y/y 23.2% | 37.7% | 24.2 | Link |
| 2024-09-30 | Q3 2024 (3M) | OK | 16.7 y/y 4.4% | 4.1 y/y -27.2% | 0.6 y/y 22.3% | 4.6 y/y -23.5% | 3.2 y/y -33.5% | 9.3 | -1.4 | 117.5 y/y 10.1% | 44.5 y/y 7.9% | 9.6% | 23.5 | Link |
| 2024-06-30 | Q2 2024 (3M) | OK | 16.1 y/y 7.2% | 6.0 y/y — | 0.5 y/y 21.6% | 6.5 y/y — | 5.5 y/y 191.3% | 5.6 | -0.8 | 112.6 y/y 7.8% | 43.6 y/y 12.6% | 52.0% | 26.5 | Link |
| 2024-03-31 | Q1 2024 (3M) | OK | 15.8 y/y 8.9% | 5.7 y/y 55.3% | 0.5 y/y 14.1% | 6.2 y/y 50.8% | 4.8 y/y 68.8% | 3.1 | -1.6 | 105.8 y/y -1.8% | 40.4 y/y -13.8% | 48.9% | 28.6 | Link |
| 2023-12-31 | FY 2023 (12M) | OK | 14.6 y/y — | — y/y — | 2.5 y/y — | — y/y — | -1.2 y/y — | 0.2 | -1.0 | 106.7 y/y — | 37.6 y/y — | 0.9% | 28.5 | Link |
| 2023-09-30 | Q3 2023 (3M) | OK | 16.0 y/y — | 5.6 y/y — | 0.5 y/y — | 6.1 y/y — | 4.7 y/y — | 7.7 | -0.9 | 106.7 y/y — | 41.2 y/y — | 15.8% | 26.3 | Link |
| 2023-06-30 | Q2 2023 (3M) | OK | 15.0 y/y — | — y/y — | 0.4 y/y — | — y/y — | -6.0 y/y — | 3.7 | -10.3 | 104.5 y/y — | 38.7 y/y — | -55.9% | 31.3 | Link |
| 2023-03-31 | Q1 2023 (3M) | OK | 14.5 y/y — | 3.6 y/y — | 0.4 y/y — | 4.1 y/y — | 2.8 y/y — | 1.3 | -2.3 | 107.8 y/y — | 46.8 y/y — | — | 21.0 | Link |
2026-03-31 Q1: Missing metrics: operating_profit.2023-06-30 Q2: Missing metrics: operating_profit.Quarterly values ($ mln)
Year-over-year change
Net debt / cash ($ mln)
Current 13.0x · 3-year average 13.7x
No dividend rows found for this issuer (checked: Yahoo Finance (ex-div)).
Reporting forms detected in loaded periods: ✓ ✓ ✓ (Balance sheet / Profit or loss (P&L) / Cash flows)